These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11583001)

  • 21. Update on neonatal blood transfusions.
    Seidel W
    Nebr Med J; 1993 Jun; 78(6):158-9. PubMed ID: 8341378
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood transfusion safety].
    Koistinen J
    Duodecim; 2004; 120(7):902-4. PubMed ID: 15154312
    [No Abstract]   [Full Text] [Related]  

  • 23. Infectious risks of blood transfusion.
    Uhl L
    Curr Hematol Rep; 2002 Nov; 1(2):156-62. PubMed ID: 12901138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Procedure for reduction of allotransfusion in operative medicine].
    Habler O
    HNO; 2003 Jan; 51(1):8-11. PubMed ID: 12557091
    [No Abstract]   [Full Text] [Related]  

  • 25. Scotblood 2007: Tackling local and global issues in transfusion medicine - donor recruitment, effective use of blood, stem cell plasticity, and vCJD.
    Bessos H; Fraser R; Seghatchian J
    Transfus Apher Sci; 2008 Feb; 38(1):77-83. PubMed ID: 18282808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Aspects of the risks associated with vCJK from plasma derivatives from human plasma].
    Burger R; Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jun; 52(6):648-9. PubMed ID: 19557456
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of a consensus conference on the topic, "Homologous blood saving methods in surgical medicine"].
    Chirurg; 1992 Jul; 63(7):suppl 110-7. PubMed ID: 1505253
    [No Abstract]   [Full Text] [Related]  

  • 28. [Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries].
    Andersen O
    Lakartidningen; 2002 Mar; 99(12):1310-4. PubMed ID: 11998162
    [No Abstract]   [Full Text] [Related]  

  • 29. [Transfusion of blood and products derived from blood].
    Wautier JL
    Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693
    [No Abstract]   [Full Text] [Related]  

  • 30. [BSE, prions, vCJD and (not only) homologous transfusion].
    Köhler M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):43-7. PubMed ID: 12522730
    [No Abstract]   [Full Text] [Related]  

  • 31. [The problems of modern transfusion science].
    Vorob'ev AI; Dabberkha NM
    Ter Arkh; 1991; 63(7):4-9. PubMed ID: 1788805
    [No Abstract]   [Full Text] [Related]  

  • 32. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 33. Consensus conference on vCJD screening of blood donors: report of the panel.
    McCullough J; Anderson D; Brookie D; Bouchard JP; Fergusson D; Joly J; Kenny N; Lee D; Megânn H; Page D; Reinharz D; Williams JR; Wilson K
    Transfusion; 2004 May; 44(5):675-83. PubMed ID: 15104647
    [No Abstract]   [Full Text] [Related]  

  • 34. [Transfusion of blood and blood derivatives. Measurements of safety, circulatory, immunologic and infectious risks and accidents].
    Rouger P; Hergon E
    Rev Prat; 1997 Sep; 47(13):1499-504. PubMed ID: 9339033
    [No Abstract]   [Full Text] [Related]  

  • 35. Blood supplies hit by vCJD fear.
    Strachan-Bennett S
    Nurs Times; 2004 Jan 6-12; 100(1):6. PubMed ID: 14735624
    [No Abstract]   [Full Text] [Related]  

  • 36. Creutzfeldt-Jakob disease.
    Clement P
    Haemophilia; 2000 Jul; 6 Suppl 1():68-78. PubMed ID: 10982271
    [No Abstract]   [Full Text] [Related]  

  • 37. Current risk for transfusion transmitted infections.
    Dodd RY
    Curr Opin Hematol; 2007 Nov; 14(6):671-6. PubMed ID: 17898573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA; Turner ML
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.
    Flan B; Arrabal S
    Transfus Clin Biol; 2007 May; 14(1):51-62. PubMed ID: 17540602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ask the ethicist: would you tell the patients?
    Culver CM
    Med Ethics (Burlingt Mass); 2000; ():3. PubMed ID: 15719509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.